Prague Registry of Electric Cardioversion
PRAGUE-ECV
1 other identifier
observational
5,000
1 country
1
Brief Summary
This single-center observational registry follows contemporary efficacy and short-term complications of elective electric cardioversion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2020
CompletedFirst Submitted
Initial submission to the registry
June 3, 2021
CompletedFirst Posted
Study publicly available on registry
June 9, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2025
CompletedJune 11, 2021
June 1, 2021
5 years
June 3, 2021
June 9, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Acute major complications
Major thromboembolic events or events related to cardioversion requiring unplanned hospitalisation (bleeding, severe bradycardia, anesthesia-related complications, heart failure etc)
Within 24 hours from the procedure
Subacute major complications
Major thromboembolic events or events related to cardioversion requiring unplanned hospitalisation (bleeding, severe bradycardia, anesthesia-related complications, acute heart failure etc), evaluated by structured phone call.
24 hours to 30 days after the procedure
Secondary Outcomes (2)
Acute minor complications
Within 24 hours from the procedure
Acute efficacy
Within 2 hours from the procedure
Study Arms (1)
Electric cardioversion
Patients who underwent elective cardioversion for atrial arrhythmia
Interventions
Electric cardioversion in short sedation according to established clinical practice and indications
Eligibility Criteria
Hemodynamically stable patients scheduled for ambulatory electric cardioversion for atrial arrhythmias based on established clinical indications.
You may qualify if:
- Consecutive out-patients undergoing electric cardioversion for atrial fibrillation, atrial tachycardia, or typical atrial flutter
You may not qualify if:
- Unstable patients with acute conditions requiring unplanned hospitalization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute for Clinical and Experimental Medicine (IKEM)
Prague, 14059, Czechia
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the Department of Acute Cardiology
Study Record Dates
First Submitted
June 3, 2021
First Posted
June 9, 2021
Study Start
January 1, 2020
Primary Completion
December 31, 2024
Study Completion
March 31, 2025
Last Updated
June 11, 2021
Record last verified: 2021-06